release

Press Release: Sanofis venglustat accepted for priority review in the US to treat type 3 Gaucher disease

Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease Paris, May 28, 2026. The…

2 weeks ago

SEMI and Global Net Corp. Release New Report on Glass Core Substrate Market and Development Trends for Semiconductors

Report Projects 67.2% CAGR for Glass Core Substrates from 2028 to 2040 as AI and HPC Accelerate Demand for Advanced…

2 weeks ago

Casio to Release MR-G Inspired by the Polar Brinicle Phenomenon

Special 30th Anniversary MR-G FROGMAN Diver's Watch with ISO 200m Water ResistanceTOKYO, May 27, 2026 /PRNewswire/ -- Casio Computer Co.,…

3 weeks ago

Press Release: ICANN Announces Next Major Internet Security Update

LOS ANGELES, May 20, 2026 /PRNewswire/ -- The Internet Corporation for Assigned Names and Numbers (ICANN) today announced that it…

3 weeks ago

Avactapresents new comparisons of pre|CISIONpayload release vs approved ADCs and AVA6207 dual payload delivery at Science Day 2026

May 06, 2026 02:00 ET  | Source: Avacta Group PLC LONDON and PHILADELPHIA, May 06, 2026 (GLOBE NEWSWIRE) -- Avacta…

1 month ago

Park Dental Partners Announces Dates for First Quarter 2026 Earnings Release and Conference Call

MINNEAPOLIS, April 24, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading dental resource organization, today announced…

2 months ago

Casio to Release G-SHOCK with Heart Rate Monitoring and Tide Graph Functions

G-LIDE Timepiece Great for Extreme SportsTOKYO, April 23, 2026 /PRNewswire/ -- Casio Computer Co., Ltd., announced today the latest addition…

2 months ago

Bybit AI Expands to Infrastructure Layer with Official MCP Release for Multi-Agent Trading

DUBAI, UAE, April 22, 2026 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, has launched its official Model…

2 months ago

Press Release: ESCMID: Sanofi’s Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study

ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study First head-to-head, double-blind, randomized phase 4 study…

2 months ago

Globus Medical Schedules First Quarter Earnings Release and Conference Call

AUDUBON, Pa., April 16, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its…

2 months ago